Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions

Inpatient costs and resource utilization in lung transplantation

Matthias Vogl, Tobias Welte, Claus Neurohr, Rudolf Hatz, Matthias Hunger, Reiner Leidl, Heidrun Lingner, Jürgen Behr, Gregor Warnecke, Axel Haverich, Jens Gottlieb, Hauke Winter, Rene Schramm, Bernhard Zwissler, Gerhard Preissler
European Respiratory Journal 2014 44: 1430; DOI:
Matthias Vogl
1Institute of Health Economics and Health Care Management, Helmholtz Zentrum Muenchen, Member of the German Center for Lung Research (DZL), Munich, Germany
2Institute of Health Economics and Health Care Management, Ludwig-Maximilians-Universität Muenchen, Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tobias Welte
6Center for Internal Medicine, Clinic for Pneumology, Medizinische Hochschule Hannover, Member of the German Center for Lung Research (DZL), Hannover, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Claus Neurohr
4Department of Int. Medicine I, Division of Pulmonary Diseases, Ludwig-Maximilians-Universität Muenchen, Member of the German Center for Lung Research (DZL), Munich, Germany
5Munich Lung Transplant Group, Ludwig-Maximilians-Universität Muenchen, Member of the German Center for Lung Research (DZL), Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rudolf Hatz
3Department of General, Visceral, Transplant, Vascular, and Thoracic Surgery, Ludwig-Maximilians-Universität Muenchen, Member of the German Center for Lung Research (DZL), Munich, Germany
5Munich Lung Transplant Group, Ludwig-Maximilians-Universität Muenchen, Member of the German Center for Lung Research (DZL), Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthias Hunger
1Institute of Health Economics and Health Care Management, Helmholtz Zentrum Muenchen, Member of the German Center for Lung Research (DZL), Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Reiner Leidl
1Institute of Health Economics and Health Care Management, Helmholtz Zentrum Muenchen, Member of the German Center for Lung Research (DZL), Munich, Germany
2Institute of Health Economics and Health Care Management, Ludwig-Maximilians-Universität Muenchen, Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Heidrun Lingner
7Center for Public Healthcare, Institute for General Practice, Medizinische Hochschule Hannover, Member of the German Center for Lung Research (DZL), Hannover, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jürgen Behr
4Department of Int. Medicine I, Division of Pulmonary Diseases, Ludwig-Maximilians-Universität Muenchen, Member of the German Center for Lung Research (DZL), Munich, Germany
5Munich Lung Transplant Group, Ludwig-Maximilians-Universität Muenchen, Member of the German Center for Lung Research (DZL), Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gregor Warnecke
8Center for Surgery, Department of Cardiothoracic, Transplantation and Vascular Surgery, Medizinische Hochschule Hannover, Member of the German Center for Lung Research (DZL), Hannover, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Axel Haverich
8Center for Surgery, Department of Cardiothoracic, Transplantation and Vascular Surgery, Medizinische Hochschule Hannover, Member of the German Center for Lung Research (DZL), Hannover, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jens Gottlieb
6Center for Internal Medicine, Clinic for Pneumology, Medizinische Hochschule Hannover, Member of the German Center for Lung Research (DZL), Hannover, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hauke Winter
3Department of General, Visceral, Transplant, Vascular, and Thoracic Surgery, Ludwig-Maximilians-Universität Muenchen, Member of the German Center for Lung Research (DZL), Munich, Germany
5Munich Lung Transplant Group, Ludwig-Maximilians-Universität Muenchen, Member of the German Center for Lung Research (DZL), Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rene Schramm
3Department of General, Visceral, Transplant, Vascular, and Thoracic Surgery, Ludwig-Maximilians-Universität Muenchen, Member of the German Center for Lung Research (DZL), Munich, Germany
5Munich Lung Transplant Group, Ludwig-Maximilians-Universität Muenchen, Member of the German Center for Lung Research (DZL), Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bernhard Zwissler
3Department of General, Visceral, Transplant, Vascular, and Thoracic Surgery, Ludwig-Maximilians-Universität Muenchen, Member of the German Center for Lung Research (DZL), Munich, Germany
5Munich Lung Transplant Group, Ludwig-Maximilians-Universität Muenchen, Member of the German Center for Lung Research (DZL), Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gerhard Preissler
3Department of General, Visceral, Transplant, Vascular, and Thoracic Surgery, Ludwig-Maximilians-Universität Muenchen, Member of the German Center for Lung Research (DZL), Munich, Germany
5Munich Lung Transplant Group, Ludwig-Maximilians-Universität Muenchen, Member of the German Center for Lung Research (DZL), Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

Objective: For lung transplantation (LTX) effective costs and major cost drivers are poorly analyzed to date. Current DRGs account merely for length of stay and hours of artificial ventilation as cost drivers. The purpose of this study was to calculate actual LTX costs and evaluate the impact of major diagnoses, socio-demographic and clinical factors on cost development, a prerequisite for the refinement of prospective payment systems (DRGs).

Methods: We used a standardized micro-costing approach calculating costs individually for each of 255 LTX patients taken care of at Hannover Medical School and University of Munich, representing 50% of the German LTX-volume in 2009/10. A generalized linear model with gamma distribution and log link function was used to determine patient and care characteristics predictive for inpatient cost.

Results: Mean LTX costs were calculated at 75,875 Euros (median 48,682 Euros, SE 4,183 Euros). Compared to emphysema/COPD patients, costs were 50%, 38%, 43%, and 23% higher for cystic fibrosis, idiopathic pulmonary fibrosis, re-transplantation, and rare end-stage lung diseases, respectively. Costs increased significantly with additional side diagnoses like bleeding complications, postoperative respiratory failure, and by additional operation/procedure codes like repetitive transfusions or surgical re-interventions.

Conclusions: Current DRGs in Germany and other countries do not adequately differentiate LTX reimbursement and may set distorting economic incentives. Besides hours of artificial ventilation and length of stay, a more accurate DRG grouping for LTX should consider the number of side diagnoses, number of operation/procedure codes and major diagnoses to enable reasonable reimbursement.

  • Transplantation
  • Health policy
  • © 2014 ERS
Previous
Back to top
Vol 44 Issue Suppl 58 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Inpatient costs and resource utilization in lung transplantation
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Inpatient costs and resource utilization in lung transplantation
Matthias Vogl, Tobias Welte, Claus Neurohr, Rudolf Hatz, Matthias Hunger, Reiner Leidl, Heidrun Lingner, Jürgen Behr, Gregor Warnecke, Axel Haverich, Jens Gottlieb, Hauke Winter, Rene Schramm, Bernhard Zwissler, Gerhard Preissler
European Respiratory Journal Sep 2014, 44 (Suppl 58) 1430;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Inpatient costs and resource utilization in lung transplantation
Matthias Vogl, Tobias Welte, Claus Neurohr, Rudolf Hatz, Matthias Hunger, Reiner Leidl, Heidrun Lingner, Jürgen Behr, Gregor Warnecke, Axel Haverich, Jens Gottlieb, Hauke Winter, Rene Schramm, Bernhard Zwissler, Gerhard Preissler
European Respiratory Journal Sep 2014, 44 (Suppl 58) 1430;
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo

Jump To

  • Article
  • Info & Metrics
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • KL-6 in serum as a biomarker for differentiation of chronic allograft dysfuntion in lung transplant. Preliminary results
  • Impact of diabetes mellitus on survival and hospitalization after lung transplantation
  • Uncontrolled non-heart-beating donors vs. brain dead donors in lung transplantation: Comparison of early and late results
Show more 8.2 Transplantation

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2022 by the European Respiratory Society